+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Contraceptive Pills Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Contraceptive Pills Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Sale

Contraceptive Pills Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 5716226
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Contraceptive Pills Market grew from USD 20.76 billion in 2024 to USD 22.12 billion in 2025. It is expected to continue growing at a CAGR of 6.50%, reaching USD 30.29 billion by 2030.

Over the past decade, contraceptive pills have evolved from a one-size-fits-all solution into a nuanced portfolio that addresses diverse patient needs, hormonal preferences, and technological advances. Shifts in patient demographics, rising demand for personalized health solutions, and increasing advocacy for reproductive rights have combined to redefine the market’s trajectory. Regulatory changes, scientific breakthroughs, and evolving societal attitudes have further accelerated innovation in formulation, delivery mechanisms, and support services. This executive summary synthesizes the most critical developments, strategic imperatives, and competitive dynamics shaping the contraceptive pills landscape today, providing decision-makers with a concise, authoritative outlook on trends, challenges, and opportunities poised to influence the industry’s next phase of growth.

Transformative Shifts Reshaping Contraceptive Landscape

Rapid advances in digital health have catalyzed a shift from traditional prescription models toward integrated telemedicine platforms and subscription-based refill services that enhance adherence and patient engagement. Personalized medicine, leveraging genomic screening and hormone-level monitoring, is transforming standard combined estrogen-progestin regimens into tailored dose-optimizations that improve efficacy and reduce side effects. Sustainability initiatives are driving manufacturers to explore eco-friendly packaging such as biodegradable blister packs with embedded reminder tablets and dispenser formats designed for minimal waste. Meanwhile, smart pill reminders and app-based compliance tracking are converging with innovative hormone formulations to create an interconnected ecosystem in which data-driven insights inform both patient behavior and future product development. As regulatory bodies embrace digital endpoints and real-world evidence, the market is witnessing a profound repositioning: from commodity-style oral contraceptives to high-value, patient-centric therapies that align with broader preventive health goals.

Cumulative Impact of 2025 US Tariffs on Contraceptive Pills

The U.S. tariff structure implemented in 2025 imposes increased duties on a range of imported active pharmaceutical ingredients (APIs) and intermediate chemicals used in the manufacture of both synthetic and bioidentical hormonal formulations. With levies targeting ethinylestradiol precursors and progestin intermediates, manufacturers have experienced a notable rise in production costs, leading to margin compression across generic and branded portfolios alike. This cost inflation has prompted several global players to accelerate onshoring efforts, driving investments in domestic API facilities and strategic supply-chain partnerships to secure raw-material availability. Retail pharmacies and distributors have responded by adjusting pricing models, offering tiered subscription plans, and negotiating cost-containment agreements with major pharmacy benefit managers. Ultimately, these measures aim to mitigate the downstream impact on patient affordability and preserve market access, even as producers and payers navigate the complexities introduced by tariff-induced cost pressures.

Key Segmentation Insights Driving Market Diversity

Type-based analysis reveals that combined oral contraceptives dominate market share, with monophasic low-dose pills steadily gaining traction among first-time users who prioritize minimized hormonal exposure, while biphasic and triphasic regimens cater to women seeking cycle mimicking and side-effect management. Progestin-only mini-pills have carved out a specialized niche for individuals with contraindications to estrogen. When viewed through the lens of hormonal composition, synthetic ethinylestradiol-based offerings featuring iron supplementation or levomefolate adjuncts stand out for their dual benefit in preventing neural-tube defects and addressing anemia. Levonorgestrel-based synthetics and bioidentical progestins further diversify the portfolio, offering clinicians precision tools to tailor therapy. Mechanism-of-action segmentation underscores the relative emphasis on ovulation inhibition-via FSH suppression or LH inhibition-versus cervical mucus thickening and endometrial alteration, each catering to distinct patient compliance scenarios. End-user demographics highlight a bifurcation between women below 35, including teenagers who value user-friendly packaging, and perimenopausal cohorts above 35 who seek relief from irregular cycles. Health-benefit segmentation indicates that acne control, menstrual regulation with pain reduction, and endometriosis treatment are the most prescribed indications. Finally, sales channels span hospital pharmacies, retail chains and independents, as well as online platforms offering either one-time purchases or subscription services, while packaging innovation in blister and dispenser formats-with or without reminder tablets-and adherence-focused solutions such as intelligent packaging all contribute to a more holistic patient experience.

Regional Dynamics Influencing Market Growth

In the Americas, established reimbursement frameworks and widespread insurance coverage support robust demand for both branded and generic contraceptive pills, while rising telehealth adoption drives digital subscription models that improve adherence. Europe, Middle East & Africa present a more heterogeneous landscape, where Western European markets focus on innovation in bioidentical formulations and adherence devices, and emerging markets in the Middle East and Africa prioritize cost-effective generics and infrastructure expansion in hospital pharmacies. Across Asia-Pacific, rapid urbanization and increasing healthcare expenditure underpin growth in synthetic hormonal options, with online pharmacies gaining momentum in China and India through app-based ordering and localized subscription plans, whereas Australia and Japan emphasize regulatory alignment with global safety standards and advanced packaging solutions.

Leading Companies Shaping Competitive Dynamics

The competitive arena is led by integrated pharmaceutical giants such as Bayer AG, Pfizer Inc., Merck & Co., Inc., and Johnson & Johnson, which leverage expansive R&D capabilities to advance next-generation formulations and delivery systems. Specialty players including AbbVie Inc. and Teva Pharmaceuticals maintain strong market share through portfolio diversification and strategic licensing agreements, while companies like Aurobindo Pharma Limited, Cipla Limited, Sun Pharmaceutical Industries Limited, Lupin Limited and Mankind Pharma Ltd. focus on cost-effective generics to serve price-sensitive segments. Emerging challengers such as Gedeon Richter PLC and Julie Product Inc. differentiate via bioidentical progestin offerings and innovation in endometriosis-focused therapies. Agility and channel expertise characterize distributors and solution providers such as Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Bionpharma Inc., Combe Incorporated, Glenmark Pharmaceuticals Limited, Northstar Rx LLC, Perrigo Company plc, Piramal Enterprises Ltd., Syzygy Healthcare Solutions, LLC, Viatris Inc., Xiromed, LLC and Mayne Pharma Group Limited, which emphasize partnerships with digital health platforms and adherence-driven packaging formats.

Actionable Recommendations for Industry Leaders

Industry leaders should invest in precision-formulation research that integrates biomarker-based patient profiling and enhanced hormone-release technologies to deepen clinical differentiation. Strengthening domestic API capabilities through strategic joint ventures or acquisitions will mitigate tariff-related cost volatility while fostering supply-chain resilience. Expanding telemedicine and subscription-based distribution partnerships will improve patient adherence, lower acquisition costs, and unlock valuable real-world data for post-market surveillance. Collaborations with digital health startups to co-develop smart packaging, AI-powered adherence monitoring, and patient-engagement apps can further elevate brand loyalty. Finally, cross-functional teams should analyze regional reimbursement frameworks to optimize market access strategies, ensuring that product launches align with evolving payer requirements and public health initiatives.

Conclusion: Strategic Outlook for Stakeholders

The contraceptive pills market stands at a pivotal juncture, defined by regulatory evolution, technological integration, and shifting patient expectations. Leaders who align product portfolios with personalized care paradigms, fortify supply chains against geopolitical and tariff disruptions, and leverage digital ecosystems to drive adherence will secure a competitive edge. As the industry transitions from traditional oral regimens toward holistic contraceptive solutions that integrate formulation, delivery, and data-driven support, stakeholders must remain agile in identifying emerging trends and responsive to evolving end-user needs. Embracing these imperatives will not only expand market penetration but also reinforce the role of contraceptive pills as a cornerstone of women’s health management.

Market Segmentation & Coverage

This research report categorizes the Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Combined Oral Contraceptives
    • Biphasic Pills
    • Monophasic Pills
      • Low-Dose Pills
      • Standard-Dose Pills
    • Triphasic Pills
  • Progestin-Only Pills
    • Mini-Pills
  • Natural Hormones
    • Bioidentical Progestins
  • Synthetic Hormones
    • Ethinylestradiol-Based
      • Iron Supplementation Containing
      • Levomefolate Containing
    • Levonorgestrel-Based
      • Iron Supplementation Containing
  • Cervical Mucus Thickening
  • Endometrium Alteration
  • Inhibition of Ovulation
    • FSH Suppression
    • LH Inhibition
  • Teenagers
  • Women Above 35
    • Perimenopausal Women
  • Women Below 35
  • Acne Control
  • Endometriosis Treatment
  • Menstrual Regulation
    • Reduction in Menstrual Pain
  • Hospital Pharmacies
  • Online Pharmacies
    • One-time Purchases
    • Subscription Services
  • Retail Pharmacies
    • Chain Pharmacies
    • Independent Pharmacies
  • Blister Packs
    • With Reminder Tablet
    • Without Reminder Tablet
  • Dispenser Packs
  • High Adherence Support
  • Low Adherence Management
    • Innovative Packaging

This research report categorizes the Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Contraceptive Pills Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AbbVie Inc.
  • Afaxys Pharma, LLC
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Bionpharma Inc.
  • Cipla Limited
  • Combe Incorporated
  • Gedeon Richter PLC
  • Glenmark Pharmaceuticals Limited
  • Johnson & Johnson Services, Inc.
  • Julie Product Inc.
  • Lupin Limited
  • Mankind Pharma Ltd.
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Northstar Rx LLC
  • Perrigo Company plc
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Sun Pharmaceutical Industries Limited
  • Syzygy Healthcare Solutions, LLC
  • Teva Pharmaceuticals
  • Viatris Inc.
  • Xiromed, LLC

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Contraceptive Pills Market, by Type
8.1. Introduction
8.2. Combined Oral Contraceptives
8.2.1. Biphasic Pills
8.2.2. Monophasic Pills
8.2.2.1. Low-Dose Pills
8.2.2.2. Standard-Dose Pills
8.2.3. Triphasic Pills
8.3. Progestin-Only Pills
8.3.1. Mini-Pills
9. Contraceptive Pills Market, by Hormonal Composition
9.1. Introduction
9.2. Natural Hormones
9.2.1. Bioidentical Progestins
9.3. Synthetic Hormones
9.3.1. Ethinylestradiol-Based
9.3.1.1. Iron Supplementation Containing
9.3.1.2. Levomefolate Containing
9.3.2. Levonorgestrel-Based
9.3.2.1. Iron Supplementation Containing
10. Contraceptive Pills Market, by Mechanism of Action
10.1. Introduction
10.2. Cervical Mucus Thickening
10.3. Endometrium Alteration
10.4. Inhibition of Ovulation
10.4.1. FSH Suppression
10.4.2. LH Inhibition
11. Contraceptive Pills Market, by End User
11.1. Introduction
11.2. Teenagers
11.3. Women Above 35
11.3.1. Perimenopausal Women
11.4. Women Below 35
12. Contraceptive Pills Market, by Health Benefits
12.1. Introduction
12.2. Acne Control
12.3. Endometriosis Treatment
12.4. Menstrual Regulation
12.4.1. Reduction in Menstrual Pain
13. Contraceptive Pills Market, by Sales Channel
13.1. Introduction
13.2. Hospital Pharmacies
13.3. Online Pharmacies
13.3.1. One-time Purchases
13.3.2. Subscription Services
13.4. Retail Pharmacies
13.4.1. Chain Pharmacies
13.4.2. Independent Pharmacies
14. Contraceptive Pills Market, by Packaging Type
14.1. Introduction
14.2. Blister Packs
14.2.1. With Reminder Tablet
14.2.2. Without Reminder Tablet
14.3. Dispenser Packs
15. Contraceptive Pills Market, by Patient Compliance Level
15.1. Introduction
15.2. High Adherence Support
15.3. Low Adherence Management
15.3.1. Innovative Packaging
16. Americas Contraceptive Pills Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Contraceptive Pills Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Contraceptive Pills Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. AbbVie Inc.
19.3.2. Afaxys Pharma, LLC
19.3.3. Amneal Pharmaceuticals, Inc.
19.3.4. Apotex Inc.
19.3.5. Aurobindo Pharma Limited
19.3.6. Bayer AG
19.3.7. Bionpharma Inc.
19.3.8. Cipla Limited
19.3.9. Combe Incorporated
19.3.10. Gedeon Richter PLC
19.3.11. Glenmark Pharmaceuticals Limited
19.3.12. Johnson & Johnson Services, Inc.
19.3.13. Julie Product Inc.
19.3.14. Lupin Limited
19.3.15. Mankind Pharma Ltd.
19.3.16. Mayne Pharma Group Limited
19.3.17. Merck & Co., Inc.
19.3.18. Northstar Rx LLC
19.3.19. Perrigo Company plc
19.3.20. Pfizer Inc.
19.3.21. Piramal Enterprises Ltd.
19.3.22. Sun Pharmaceutical Industries Limited
19.3.23. Syzygy Healthcare Solutions, LLC
19.3.24. Teva Pharmaceuticals
19.3.25. Viatris Inc.
19.3.26. Xiromed, LLC
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. CONTRACEPTIVE PILLS MARKET MULTI-CURRENCY
FIGURE 2. CONTRACEPTIVE PILLS MARKET MULTI-LANGUAGE
FIGURE 3. CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY HEALTH BENEFITS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY HEALTH BENEFITS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2024 VS 2030 (%)
FIGURE 22. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BIPHASIC PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY LOW-DOSE PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY STANDARD-DOSE PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC PILLS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY TRIPHASIC PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MINI-PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILLS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY NATURAL HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BIOIDENTICAL PROGESTINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY NATURAL HORMONES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY SYNTHETIC HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ETHINYLESTRADIOL-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY IRON SUPPLEMENTATION CONTAINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY LEVOMEFOLATE CONTAINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ETHINYLESTRADIOL-BASED, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY IRON SUPPLEMENTATION CONTAINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL-BASED, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY SYNTHETIC HORMONES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CERVICAL MUCUS THICKENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ENDOMETRIUM ALTERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY INHIBITION OF OVULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY FSH SUPPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY LH INHIBITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY INHIBITION OF OVULATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY TEENAGERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN ABOVE 35, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PERIMENOPAUSAL WOMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN ABOVE 35, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN BELOW 35, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ACNE CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ENDOMETRIOSIS TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MENSTRUAL REGULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REDUCTION IN MENSTRUAL PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MENSTRUAL REGULATION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ONE-TIME PURCHASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY SUBSCRIPTION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY WITH REMINDER TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY WITHOUT REMINDER TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISPENSER PACKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY HIGH ADHERENCE SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY LOW ADHERENCE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY INNOVATIVE PACKAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY LOW ADHERENCE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC PILLS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILLS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY NATURAL HORMONES, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY SYNTHETIC HORMONES, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY ETHINYLESTRADIOL-BASED, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL-BASED, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY INHIBITION OF OVULATION, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN ABOVE 35, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY MENSTRUAL REGULATION, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY LOW ADHERENCE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC PILLS, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILLS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY NATURAL HORMONES, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY SYNTHETIC HORMONES, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY ETHINYLESTRADIOL-BASED, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL-BASED, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY INHIBITION OF OVULATION, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN ABOVE 35, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY MENSTRUAL REGULATION, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY LOW ADHERENCE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC PILLS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILLS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY NATURAL HORMONES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY SYNTHETIC HORMONES, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY ETHINYLESTRADIOL-BASED, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL-BASED, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY INHIBITION OF OVULATION, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN ABOVE 35, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY MENSTRUAL REGULATION, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY LOW ADHERENCE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 138. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 140. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC PILLS, 2018-2030 (USD MILLION)
TABLE 141. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILLS, 2018-2030 (USD MILLION)
TABLE 142. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 143. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY NATURAL HORMONES, 2018-2030 (USD MILLION)
TABLE 144. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY SYNTHETIC HORMONES, 2018-2030 (USD MILLION)
TABLE 145. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY ETHINYLESTRADIOL-BASED, 2018-2030 (USD MILLION)
TABLE 146. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL-BASED, 2018-2030 (USD MILLION)
TABLE 147. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 148. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY INHIBITION OF OVULATION, 2018-2030 (USD MILLION)
TABLE 149. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN ABOVE 35, 2018-2030 (USD MILLION)
TABLE 151. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
TABLE 152. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY MENSTRUAL REGULATION, 2018-2030 (USD MILLION)
TABLE 153. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 155. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 156. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 157. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 158. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 159. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY LOW ADHERENCE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 160. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 162. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC PILLS, 2018-2030 (USD MILLION)
TABLE 163. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILLS, 2018-2030 (USD MILLION)
TABLE 164. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 165. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY NATURAL HORMONES, 2018-2030 (USD MILLION)
TABLE 166. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY SYNTHETIC HORMONES, 2018-2030 (USD MILLION)
TABLE 167. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY ETHINYLESTRADIOL-BASED, 2018-2030 (USD MILLION)
TABLE 168. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL-BASED, 2018-2030 (USD MILLION)
TABLE 169. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 170. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY INHIBITION OF OVULATION, 2018-2030 (USD MILLION)
TABLE 171. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN ABOVE 35, 2018-2030 (USD MILLION)
TABLE 173. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
TABLE 174. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY MENSTRUAL REGULATION, 2018-2030 (USD MILLION)
TABLE 175. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 177. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 178. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 179. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 180. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 181. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY LOW ADHERENCE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC PILLS, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILLS, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY NATURAL HORMONES, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY SYNTHETIC HORMONES, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY ETHINYLESTRADIOL-BASED, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL-BASED, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY INHIBITION OF OVULATION, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN ABOVE 35, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY MENSTRUAL REGULATION, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY LOW ADHERENCE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC PILLS, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILLS, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY NATURAL HORMONES, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY SYNTHETIC HORMONES, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY ETHINYLESTRADIOL-BASED, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL-BASED, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY INHIBITION OF OVULATION, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN ABOVE 35, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY MENSTRUAL REGULATION, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY LOW ADHERENCE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC PILLS, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILLS, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY NATURAL HORMONES, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY SYNTHETIC HORMONES, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY ETHINYLESTRADIOL-BASED, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL-BASED, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY INHIBITION OF OVULATION, 2018-2030 (USD MILLION)
TABLE 239. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN ABOVE 35, 2018-2030 (USD MILLION)
TABLE 241. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
TABLE 242. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY MENSTRUAL REGULATION, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY LOW ADHERENCE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 250. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 251. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 252. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC PILLS, 2018-2030 (USD MILLION)
TABLE 253. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILLS, 2018-2030 (USD MILLION)
TABLE 254. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 255. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY NATURAL HORMONES, 2018-2030 (USD MILLION)
TABLE 256. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY SYNTHETIC HORMONES, 2018-2030 (USD MILLION)
TABLE 257. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY ETHINYLESTRADIOL-BASED, 2018-2030 (USD MILLION)
TABLE 258. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL-BASED, 2018-2030 (USD MILLION)
TABLE 259. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 260. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY INHIBITION OF OVULATION, 2018-2030 (USD MILLION)
TABLE 261. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN ABOVE 35, 2018-2030 (USD MILLION)
TABLE 263. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
TABLE 264. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY MENSTRUAL REGULATION, 2018-2030 (USD MILLION)
TABLE 265. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 267. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 268. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 269. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 270. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 271. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY LOW ADHERENCE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 272. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 273. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 274. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC PILLS, 2018-2030 (USD MILLION)
TABLE 275. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILLS, 2018-2030 (USD MILLION)
TABLE 276. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 277. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY NATURAL HORMONES, 2018-2030 (USD MILLION)
TABLE 278. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY SYNTHETIC HORMONES, 2018-2030 (USD MILLION)
TABLE 279. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY ETHINYLESTRADIOL-BASED, 2018-2030 (USD MILLION)
TABLE 280. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL-BASED, 2018-2030 (USD MILLION)
TABLE 281. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 282. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY INHIBITION OF OVULATION, 2018-2030 (USD MILLION)
TABLE 283. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN ABOVE 35, 2018-2030 (USD MILLION)
TABLE 285. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
TABLE 286. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY MENSTRUAL REGULATION, 2018-2030 (USD MILLION)
TABLE 287. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 289. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 290. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 291. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 292. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 293. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY LOW ADHERENCE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 294. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 295. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 296. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC PILLS, 2018-2030 (USD MILLION)
TABLE 297. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILLS, 2018-2030 (USD MILLION)
TABLE 298. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 299. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY NATURAL HORMONES, 2018-2030 (USD MILLION)
TABLE 300. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY SYNTHETIC HORMONES, 2018-2030 (USD MILLION)
TABLE 301. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY ETHINYLESTRADIOL-BASED, 2018-2030 (USD MILLION)
TABLE 302. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL-BASED, 2018-2030 (USD MILLION)
TABLE 303. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 304. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY INHIBITION OF OVULATION, 2018-2030 (USD MILLION)
TABLE 305. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN ABOVE 35, 2018-2030 (USD MILLION)
TABLE 307. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY HEALTH BENEFITS, 2018-2030 (USD MILLION)
TABLE 308. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY MENSTRUAL REGULATION, 2018-2030 (USD MILLION)
TABLE 309. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING TYPE, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACKS, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY PATIENT COMPLIANCE LEVEL, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY LOW ADHERENCE MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 316. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 317. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 318. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC PILLS, 2018-2030 (USD MILLION)
TABLE 319. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILLS, 2018-2030 (USD MILLION)
TABLE 320. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY HORMONAL COMPOSITION, 2018-2030 (USD MILLION)
TABLE 321. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY NATURAL HORMONES, 2018-2030 (USD MILLION)
TABLE 322. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY SYNTHETIC HORMONES, 2018-2030 (USD MILLION)
TABLE 323. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY ETHINYLESTRADIOL-BASED, 2018-2030 (USD MILLION)
TABLE 324. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL-BASED, 2018-2030 (USD MILLION)
TABLE 325. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 326. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY INHIBITION OF OVULATION, 2018-2030 (USD MILLION)
TABLE 327. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY WOMEN ABOVE 35, 2018-2030 (USD MILLION)
TABLE 329. JAPAN

Companies Mentioned

  • AbbVie Inc.
  • Afaxys Pharma, LLC
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Bionpharma Inc.
  • Cipla Limited
  • Combe Incorporated
  • Gedeon Richter PLC
  • Glenmark Pharmaceuticals Limited
  • Johnson & Johnson Services, Inc.
  • Julie Product Inc.
  • Lupin Limited
  • Mankind Pharma Ltd.
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Northstar Rx LLC
  • Perrigo Company plc
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Sun Pharmaceutical Industries Limited
  • Syzygy Healthcare Solutions, LLC
  • Teva Pharmaceuticals
  • Viatris Inc.
  • Xiromed, LLC

Methodology

Loading
LOADING...

Related Topics

Related Reports

Emergency Contraceptive Pills Market by Type, Category, Age Group, Distribution - Global Forecast 2025-2030 - Product Image

Emergency Contraceptive Pills Market by Type, Category, Age Group, Distribution - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Oral Contraceptive Pills Market by Type, Age Group, Category, Distribution - Global Forecast 2025-2030 - Product Image

Oral Contraceptive Pills Market by Type, Age Group, Category, Distribution - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 150 Pages
  • Global
From
Emergency Contraceptive Pills Market 2025-2033 - Product Image

Emergency Contraceptive Pills Market 2025-2033

  • Report
  • 142 Pages
  • Global
From
Emergency Contraceptive Pills - Global Strategic Business Report - Product Image

Emergency Contraceptive Pills - Global Strategic Business Report

  • Report
  • 246 Pages
  • Global
From

About the Birth Control Pill Market

The Birth Control Pill is a form of contraception used by women to prevent pregnancy. It is a hormonal medication taken orally, usually once a day, and works by preventing ovulation and fertilization. It is one of the most popular forms of contraception in the world, and is widely used by women of all ages. The Birth Control Pill is an important part of Women's Health, as it provides women with the ability to control their reproductive health and plan their families. It is also used to treat a variety of medical conditions, such as endometriosis, polycystic ovary syndrome, and acne. The Birth Control Pill market is highly competitive, with many companies offering different types of pills. Some of the major players in the market include Bayer, Pfizer, Merck, and Teva Pharmaceuticals. Other companies include Mylan, Allergan, and Actavis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.